A Phase I Dose-finding Study of Metformin in Combination With Concurrent Cisplatin and Radiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Metformin (Primary) ; Cisplatin
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions
- 13 Jan 2017 Planned End Date changed from 1 Mar 2020 to 1 Mar 2021.
- 13 Jan 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
- 07 Jun 2016 Trial design presented at the 52nd Annual Meeting of the American Society of Clinical Oncology